These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28822593)

  • 21. The pathological role and prognostic impact of miR-181 in acute myeloid leukemia.
    Weng H; Lal K; Yang FF; Chen J
    Cancer Genet; 2015 May; 208(5):225-9. PubMed ID: 25686674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
    Huang Y; Zou Y; Lin L; Ma X; Chen H
    Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.
    Yang DQ; Zhou JD; Wang YX; Deng ZQ; Yang J; Yao DM; Qian Z; Yang L; Lin J; Qian J
    Int J Lab Hematol; 2017 Feb; 39(1):42-50. PubMed ID: 27577964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
    Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
    Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.
    Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ
    J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA.
    Qi HX; Cao Q; Zhou GP; Sun XZ; Zhou WD; Hong Z; Hu J; Juan CX; Li S; Kuai WX
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5351-5359. PubMed ID: 31298387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of serum miR-4262 predicts clinical outcome of patients with acute myeloid leukemia.
    Han GT; Sun ZL
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2172-2176. PubMed ID: 28537666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-206 serves as a tumor suppressor in pediatric acute myeloid leukemia by targeting Cyclin D1.
    Liu H; Wu H; Qin X
    Pathol Res Pract; 2019 Oct; 215(10):152554. PubMed ID: 31431298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.
    Zhou JD; Zhang LC; Zhang TJ; Gu Y; Wu DH; Zhang W; Ma JC; Wen XM; Guo H; Lin J; Qian J
    J Transl Med; 2018 May; 16(1):135. PubMed ID: 29784043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.
    Tang X; Zhou J; Zhang J; Zhou LY; Zhai LL; Vanessa ME; Yi J; Yi YY; Lin J; Deng ZQ
    Acta Haematol; 2018; 139(2):89-95. PubMed ID: 29393096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
    Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia.
    Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH
    J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia.
    Guo Y
    Bioengineered; 2019 Dec; 10(1):345-352. PubMed ID: 31411110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA SNHG5 is up-regulated and serves as a potential prognostic biomarker in acute myeloid leukemia.
    Li J; Sun CK
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3342-3347. PubMed ID: 29917184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia.
    Bai J; Guo A; Hong Z; Kuai W
    Onco Targets Ther; 2012; 5():213-9. PubMed ID: 23055746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the miR-148/152 Family in Acute Myeloid Leukemia and its Clinical Significance.
    Wang XX; Zhang R; Li Y
    Med Sci Monit; 2017 Oct; 23():4768-4778. PubMed ID: 28978904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased miR-144 expression as a non-invasive biomarker for acute myeloid leukemia patients.
    Zhao Q; Li J; Chen S; Shen K; Ai G; Dai X; Xie B; Shi Y; Jiang S; Feng J; Li W
    Pharmazie; 2017 Apr; 72(4):232-235. PubMed ID: 29441994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
    Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
    BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.